Works about IMMUNE checkpoint inhibitors
Results: 5000
A Mechanical Immune Checkpoint Inhibitor Stiffens Tumor Cells to Potentiate Antitumor Immunity.
- Published in:
- Angewandte Chemie, 2025, v. 137, n. 5, p. 1, doi. 10.1002/ange.202417518
- By:
- Publication type:
- Article
Efficacy and safety of cadonilimab (PD-1/CTLA-4 bispecific) in combination with chemotherapy in anti-PD-1-resistant recurrent or metastatic nasopharyngeal carcinoma: a single-arm, open-label, phase 2 trial.
- Published in:
- BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-03985-4
- By:
- Publication type:
- Article
Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer.
- Published in:
- Cancer (0008543X), 2025, v. 131, n. 4, p. 1, doi. 10.1002/cncr.35757
- By:
- Publication type:
- Article
Expert Discussion: ESMO 2024.
- Published in:
- 2025
- By:
- Publication type:
- Conference Paper/Materials
Utility of Assessing Early Tumor Shrinkage as an Efficacy Predictor in Patients with Non-Surgically Indicated or Recurrent Esophageal Cancer Treated with Nivolumab plus Ipilimumab.
- Published in:
- Oncology, 2025, v. 103, n. 3, p. 167, doi. 10.1159/000540851
- By:
- Publication type:
- Article
Identification of Biomarkers for Assessing Treatment Efficacy of Chemotherapy plus Nivolumab as the First Line in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.
- Published in:
- Oncology, 2025, v. 103, n. 3, p. 201, doi. 10.1159/000540841
- By:
- Publication type:
- Article
Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 3, p. 830, doi. 10.1210/clinem/dgae512
- By:
- Publication type:
- Article
Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 5, p. 501, doi. 10.3390/medicina57050501
- By:
- Publication type:
- Article
Efficacy and Safety of Low-Dose Lenvatinib and Toripalimab in Patients With Recurrent Platinum-Resistant Ovarian Cancer: Study Protocol of a Multicenter, Open-Label, Single-Arm, Phase II Clinical Trial.
- Published in:
- International Journal of Women's Health, 2025, v. 17, p. 325, doi. 10.2147/IJWH.S502665
- By:
- Publication type:
- Article
Simultaneous Anti-Tuberculosis and Anti-Tumor Treatment with Immune Checkpoint Inhibitors for Co-Existent Pulmonary Tuberculosis and Advanced Lung Cancer.
- Published in:
- Infection & Drug Resistance, 2025, v. 18, p. 107, doi. 10.2147/IDR.S497006
- By:
- Publication type:
- Article
Pembrolizumab for the Treatment of Locally Advanced Cutaneous Squamous Cell Carcinoma: Patient Selection and Special Considerations.
- Published in:
- Cancer Management & Research, 2025, v. 17, p. 211, doi. 10.2147/CMAR.S379963
- By:
- Publication type:
- Article
Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3).
- Published in:
- Cancer Management & Research, 2025, v. 17, p. 103, doi. 10.2147/CMAR.S484947
- By:
- Publication type:
- Article
Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer.
- Published in:
- Cancer Management & Research, 2025, v. 17, p. 171, doi. 10.2147/CMAR.S405590
- By:
- Publication type:
- Article
Clinical Use of Dostarlimab in Advanced Stage and Recurrent Endometrial Cancer: Patient Selection and Perspectives.
- Published in:
- Cancer Management & Research, 2025, v. 17, p. 161, doi. 10.2147/CMAR.S341469
- By:
- Publication type:
- Article
Addition of thoracic radiotherapy to a PD-L1 inhibitor plus chemotherapy regimen delays brain metastasis onset in extensive-stage small cell lung cancer patients without baseline brain metastasis.
- Published in:
- Respiratory Research, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12931-025-03157-1
- By:
- Publication type:
- Article
Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response prediction.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1540477
- By:
- Publication type:
- Article
AWT020: a novel fusion protein harnessing PD-1 blockade and selective IL-2 Cis-activation for enhanced anti-tumor immunity and diminished toxicity.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1537466
- By:
- Publication type:
- Article
Identification and functional characterization of m1A-related genes in colorectal cancer: implications for prognosis, immune infiltration, and therapeutic strategies.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1532602
- By:
- Publication type:
- Article
Editorial: Current insights in cancer metabolism and T cell based tumor immunity.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1566491
- By:
- Publication type:
- Article
Combination of cadonilimab (PD-1/CTLA-4 bispecific antibody) and apatinib as salvage therapy achieves partial response in MSI-H advanced gastric cancer: a case report.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1533700
- By:
- Publication type:
- Article
Predictors of severity and onset timing of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a retrospective analysis.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1508512
- By:
- Publication type:
- Article
New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1438001
- By:
- Publication type:
- Article
Characteristics, Incidence, and Management of Immune Checkpoint Inhibitors Related Cardiovascular Adverse Events in Real-World Practice-A Retrospective Study in Chinese Han Population.
- Published in:
- Therapeutics & Clinical Risk Management, 2025, v. 21, p. 125, doi. 10.2147/TCRM.S477417
- By:
- Publication type:
- Article
THOR: a TMB heterogeneity-adaptive optimization model predicts immunotherapy response using clonal genomic features in group-structured data.
- Published in:
- Briefings in Bioinformatics, 2025, v. 26, n. 1, p. 1, doi. 10.1093/bib/bbae648
- By:
- Publication type:
- Article
Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis.
- Published in:
- Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01678-2
- By:
- Publication type:
- Article
Efficacy and safety analysis of atezolizumab continuation beyond progression in extensive-stage small cell lung cancer.
- Published in:
- Clinical & Experimental Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1007/s10238-025-01606-1
- By:
- Publication type:
- Article
Editorial: Understanding bladder tumor microenvironment to optimize immunotherapy.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1566407
- By:
- Publication type:
- Article
m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1538658
- By:
- Publication type:
- Article
Serum Alpha-fetoprotein Associated with Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma: A Meta-Analysis and a Retrospective Cohort Study.
- Published in:
- Hepatitis Monthly, 2024, v. 24, n. 1, p. 1, doi. 10.5812/hepatmon-145022
- By:
- Publication type:
- Article
The interplay between programmed death ligand 1 (PD-L1) expression and human papillomavirus (HPV) genotypes in cervical carcinomas: findings of a Nigerian Tertiary Hospital.
- Published in:
- Pan African Medical Journal, 2024, v. 48, p. 1, doi. 10.11604/pamj.2024.48.90.42773
- By:
- Publication type:
- Article
Efficacy and safety of PD-1/PD-L1 inhibitors for natural killer/T-cell lymphoma: a single-arm meta-analysis.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13812-x
- By:
- Publication type:
- Article
Vascular E-selectin Expression Recognized by the U12-12 Monoclonal Antibody as a Predictive Marker for Steroid Resistance in Immune Checkpoint Inhibitor-related Colitis.
- Published in:
- Journal of Histochemistry & Cytochemistry, 2025, v. 73, n. 1/2, p. 81, doi. 10.1369/00221554251320703
- By:
- Publication type:
- Article
A Case of Rapidly Progressing Urothelial Carcinoma Arising After Living Donor Kidney Transplantation Treated with Chemotherapy and Immune Checkpoint Inhibitors.
- Published in:
- Yonago Acta Medica, 2025, v. 68, n. 1, p. 75, doi. 10.33160/yam.2025.02.009
- By:
- Publication type:
- Article
m6A RNA methylation: a pivotal regulator of tumor immunity and a promising target for cancer immunotherapy.
- Published in:
- Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06221-y
- By:
- Publication type:
- Article
Distant metastasis of oral squamous cell carcinoma: immune escape mechanism and new perspectives on treatment.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01997-3
- By:
- Publication type:
- Article
Unveiling tumor-infiltrating immune cell-driven immune-mediated drug resistance in clear cell renal cell carcinoma: prognostic insights and therapeutic strategies.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01890-z
- By:
- Publication type:
- Article
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1536642
- By:
- Publication type:
- Article
Editor's view—Safety first: optimising treatment modalities.
- Published in:
- Age & Ageing, 2025, v. 54, n. 2, p. 1, doi. 10.1093/ageing/afaf032
- By:
- Publication type:
- Article
Tumour mutational burden using a targeted panel approach for comprehensive tumour profiling focusing on colorectal cancer.
- Published in:
- Hereditary Cancer in Clinical Practice, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s13053-025-00308-9
- By:
- Publication type:
- Article
Checkpoint inhibitor-related myasthenia-myocarditis-myositis overlap syndrome in the orbit.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Targeting Metabolic Vulnerabilities to Combat Drug Resistance in Cancer Therapy.
- Published in:
- Journal of Personalized Medicine, 2025, v. 15, n. 2, p. 50, doi. 10.3390/jpm15020050
- By:
- Publication type:
- Article
Prognostic Biomarkers in Isocitrate Dehydrogenase Wild-Type Glioblastoma: A Focus on B7-H3.
- Published in:
- Brain Sciences (2076-3425), 2025, v. 15, n. 2, p. 212, doi. 10.3390/brainsci15020212
- By:
- Publication type:
- Article
Lipid-siRNA Conjugates Targeting High PD-L1 Expression as Potential Novel Immune Checkpoint Inhibitors.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 2, p. 293, doi. 10.3390/biom15020293
- By:
- Publication type:
- Article
UVC-Induced Oxidative Stress and DNA Damage Repair Status in Head and Neck Squamous Cell Carcinoma Patients with Different Responses to Nivolumab Therapy.
- Published in:
- Biology (2079-7737), 2025, v. 14, n. 2, p. 195, doi. 10.3390/biology14020195
- By:
- Publication type:
- Article
Extracellular Vesicle-Based Strategies for Tumor Immunotherapy.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 257, doi. 10.3390/pharmaceutics17020257
- By:
- Publication type:
- Article
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 216, doi. 10.3390/pharmaceutics17020216
- By:
- Publication type:
- Article
Clinical Progress of Fruquintinib in Colorectal Cancer: An Overview.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 280, doi. 10.3390/ph18020280
- By:
- Publication type:
- Article
Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 207, doi. 10.3390/ph18020207
- By:
- Publication type:
- Article
Recent Advances in Mesothelioma Treatment: Immunotherapy, Advanced Cell Therapy, and Other Innovative Therapeutic Modalities.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 694, doi. 10.3390/cancers17040694
- By:
- Publication type:
- Article
Deeper Analysis to Identify the True Benefit of ICIs Immunotherapy in First-Line Treatment for Non-HER2-Positive/HER2-Negative Advanced or Metastatic Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC).
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 657, doi. 10.3390/cancers17040657
- By:
- Publication type:
- Article